These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 18554227)

  • 1. Treatment of disseminated superficial actinic porokeratosis with topical diclofenac gel: a case series.
    Vlachou C; Kanelleas AI; Martin-Clavijo A; Berth-Jones J
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1343-5. PubMed ID: 18554227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diclofenac sodium 3% gel as a potential treatment for disseminated superficial actinic porokeratosis.
    Marks S; Varma R; Cantrell W; Chen SC; Gold M; Muellenhoff M; Elewski B
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):42-5. PubMed ID: 18702625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).
    Nelson C; Rigel D; Smith S; Swanson N; Wolf J
    J Drugs Dermatol; 2004; 3(4):401-7. PubMed ID: 15303784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses.
    Mastrolonardo M
    Clin Exp Dermatol; 2009 Jan; 34(1):33-5. PubMed ID: 18616726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
    Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
    Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genital porokeratosis: treatment with diclofenac topical gel.
    Kluger N; Dereure O; Guilhou JJ; Guillot B
    J Dermatolog Treat; 2007; 18(3):188-90. PubMed ID: 17538810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
    Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety.
    Martin GM; Stockfleth E
    J Drugs Dermatol; 2012 May; 11(5):600-8. PubMed ID: 22527428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of actinic cheilitis using diclofenac 3% gel: a report of six cases.
    Ulrich C; Forschner T; Ulrich M; Stockfleth E; Sterry W; Termeer C
    Br J Dermatol; 2007 May; 156 Suppl 3():43-6. PubMed ID: 17488406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated superficial actinic porokeratosis (DSAP): significant improvement after local administration of calcipotriol/betamethasone gel?
    Tchernev G; Chokoeva AA; Ivanova B; Mangarov H; Vidolova NG
    Wien Med Wochenschr; 2017 Mar; 167(3-4):85-88. PubMed ID: 27468973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.
    Berlin JM; Rigel DS
    J Drugs Dermatol; 2008 Jul; 7(7):669-73. PubMed ID: 18664159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does progression from actinic keratosis and Bowen's disease end with treatment: diclofenac 3% gel, an old drug in a new environment?
    Patel MJ; Stockfleth E
    Br J Dermatol; 2007 May; 156 Suppl 3():53-6. PubMed ID: 17488408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses.
    Rivers JK; McLean DI
    Arch Dermatol; 1997 Oct; 133(10):1239-42. PubMed ID: 9382562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
    Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses.
    Rivers JK
    Skin Therapy Lett; 2004 Jan; 9(1):1-3. PubMed ID: 14716439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoallergic contact dermatitis from topical diclofenac in Solaraze gel.
    Kowalzick L; Ziegler H
    Contact Dermatitis; 2006 Jun; 54(6):348-9. PubMed ID: 16787462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-arm, open-label efficacy and tolerability study of diclofenac sodium 3% gel for the treatment of actinic keratosis of the upper and lower lip.
    Nelson CG; Spencer J; Nelson CG
    J Drugs Dermatol; 2007 Jul; 6(7):712-7. PubMed ID: 17763595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases.
    Ulrich C; Hackethal M; Ulrich M; Howorka A; Forschner T; Sterry W; Stockfleth E
    Br J Dermatol; 2007 May; 156 Suppl 3():40-2. PubMed ID: 17488405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group.
    Pflugfelder A; Welter AK; Leiter U; Weide B; Held L; Eigentler TK; Dirschka T; Stockfleth E; Nashan D; Garbe C;
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):48-53. PubMed ID: 21414035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facial presentation of disseminated superficial actinic porokeratosis.
    Sawyer R; Picou KA
    Ear Nose Throat J; 1989 Jan; 68(1):57-9. PubMed ID: 2721409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.